1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsLung Diseases Research is sponsored by Department of Health And Human Services. This opportunity supports mission-aligned projects and measurable outcomes.
Get alerted about grants like this
Get emailed when new opportunities from “Department of Health And Human Services” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Division of Lung Diseases | NHLBI, NIH < Back To Divisions, Offices and Centers Division of Lung Diseases Division of Lung Diseases The Division of Lung Diseases (DLD) supports research on the causes, diagnosis, prevention, and treatment of lung diseases and sleep disorders.
The Division is responsible for monitoring the latest research developments in the extramural scientific community, as well as identifying research gaps and needs, obtaining advice from experts in the field, and implementing programs to address new opportunities.
Research is funded through investigator-initiated and Institute-initiated grant programs and through contract programs in areas including asthma, bronchopulmonary dysplasia, chronic obstructive pulmonary disease, cystic fibrosis, respiratory neurobiology, sleep-disordered breathing, critical care and acute lung injury, developmental biology, pediatric pulmonary diseases, immunologic and fibrotic pulmonary disease, rare lung disorders, pulmonary vascular disease, pulmonary manifestations of HIV/AIDS, tuberculosis, and other respiratory pathogens.
The DLD houses four branches -the Acute and Infectious Lung Diseases Branch, the Lung Development and Pediatric Diseases Branch, the Obstructive Lung Diseases Branch, and the Restrictive and Vascular Lung Diseases Branch – as well as the National Center on Sleep Disorders Research. Related Scientific Focus Areas Gustavo Matute-Bello, M. D.
Acute and Infectious Lung Diseases Branch The Acute and Infectious Lung Diseases Branch supports research and research training in acute lung injury, acute respiratory distress syndrome, critical care, pneumonia, sepsis, mechanical ventilation, lung transplantation, HIV/AIDS, tuberculosis and other infectious diseases, as well as digital health.
Lung Development and Pediatric Diseases Branch The Lung Development and Pediatric Diseases Branch supports research and research training in lung development, stem cells and other lung cell lineages, surfactant, host responses to early-life infections, neonatal and pediatric conditions such as bronchopulmonary dysplasia, cystic fibrosis, and primary ciliary dyskinesia, and related gene editing strategies.
Marrah Lachowicz-Scroggins marrah. lachowicz-scroggins@nih. gov Obstructive Lung Diseases Branch The Obstructive Lung Diseases Branch supports research and research training in chronic obstructive pulmonary disease, asthma, bronchiolitis, TH1/2 immunity, e-cigarette or vaping use-associated lung injury, lung imaging, and related population studies.
Restrictive and Vascular Lung Diseases Branch The Restrictive and Vascular Lung Diseases Branch supports research and research training in pulmonary fibrosis and other interstitial or rare lung diseases in adults, sarcoidosis, pulmonary vascular disease including pulmonary hypertension and right heart failure, pulmonary embolism, lung aging, data science, and genomics.
National Center on Sleep Disorders Research The National Center on Sleep Disorders Research supports research and research training related to sleep disordered breathing, and the fundamental functions of sleep and circadian rhythms.
The Center also stewards several forums that facilitate the coordination of sleep research across NIH, other federal agencies and outside organizations, including the Sleep Disorders Research Advisory Board and a Trans-NIH Sleep Research Coordinating Committee. The Center also participates in the translation of new sleep research findings for dissemination to health care professionals and the public.
The Office of the Director oversees scientific, budgetary and administrative efforts across the Division’s branches.
Strategic leadership and coordination is provided for the development and implementation of lung and sleep research funding mechanisms and initiatives; direction and management of translational, clinical and implementation research programs; grant and contract administration; scientific workforce development; and intra- and inter-agency collaborations. Take a look back at our Division of Lung Disease 50th Anniversary highlights.
Related Scientific Focus Areas Sleep Science and Sleep Disorders A cystic fibrosis cure for all? Gene editing shows promise Could next-generation gene editing mean a cure for cystic fibrosis (CF)? There's been a lot of advancement on the disease in the last decade, but there are still those living with the disease who get no relief from current treatments - especially those for whom health disparities already exist.
Paul McCray, M. D. , professor of pediatrics, and...
Division of Lung Diseases Neurodevelopmental Disorders and Sleep Workshop Day 1: 11:00 a. m. - 3:15 p.
m. ET Day 2: 11:00 a. m.
- 3:40 p. m. ET During this workshop, multidisciplinary experts explored past and current findings and identify research gaps in neurodevelopmental and s...
Division of Lung Diseases Division of Lung Diseases National Heart, Lung, and Blood Institute Two Rockledge Center, Suite 10042 6701 Rockledge Dr. MSC 7952
According to the current listing, eligibility includes: Any nonprofit organization engaged in biomedical research and institutions or companies organized for profit may apply for almost any kind of grant. Confirm the full requirements in the official notice before applying.
Yes — Lung Diseases Research is offered by Department of Health And Human Services and this listing comes from SAM.gov, an official U.S. federal source. Federal applications generally require registrations (for example SAM.gov or an agency submission portal), so allow extra lead time.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
This initiative will stimulate and support innovative research by small business concerns that may lead to the development of novel technologies for the early diagnosis, monitoring and treatment of micro and macro vascular complications of diabetes which are associated with significant morbidity and mortality of the disease and high costs to the health care system. Funding Opportunity Number: PA-14-058. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL.
The STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleThe Elevance Health Foundation's FY2026 Maternal/Infant Health cycle offers grants around $1 million (1–3 years, 15% indirects) to reduce pre-term birth and severe maternal morbidity. But eligibility hinges on a specific 501(c)(3) subsection test, funding concentrates in 10 states plus national scalable programs, and a corporate payer-funder judges you on measurable outcomes, not need. Here is how to read this RFP and compete before the July 31 deadline.
Read articleElevance Health Foundation's maternal/infant health RFP closes July 31, 2026, part of a five-year, $150 million commitment. Last cycle it awarded 29 grants totaling $6.5M across the pregnancy continuum. Here is what the funder actually rewards — measurable disparity reduction, a 15% indirect-cost cap, and scalable models — plus how nonprofits in the 10 priority states should frame a competitive proposal.
Read article